Free Trial
→ Many investors are about to lose everything (From Porter & Company) (Ad)tc pixel Free SRI Stock Alerts

Stoneridge (SRI) Financials

Stoneridge logo
$5.14 -0.27 (-4.90%)
Closing price 03:59 PM Eastern
Extended Trading
$5.12 -0.02 (-0.39%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Stoneridge

Annual Income Statements for Stoneridge

This table shows Stoneridge's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 23 77 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Consolidated Net Income / (Loss)		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Net Income / (Loss) Continuing Operations		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Total Pre-Tax Income 		20 39 53 65 68 -11 12 -11 -1.92 -14 -55
Total Operating Income		 28 44 57 67 71 -7.66 15 2.94 13 -0.38 -39
Total Gross Profit		 177 195 248 257 214 154 167 175 201 189 171
Total Revenue		 645 696 824 866 834 648 770 900 976 908 861
Operating Revenue		 645 696 824 866 834 648 770 900 976 908 861
Total Cost of Revenue		 468 501 576 610 621 494 604 725 775 719 690
Operating Cost of Revenue		 468 501 576 610 621 494 604 725 775 719 690
Total Operating Expenses		 149 151 191 190 142 162 151 172 188 190 210
Selling, General & Admin Expense		 110 111 142 139 124 112 116 107 117 117 126
Research & Development Expense		 39 40 49 51 52 49 66 65 71 72 63
Impairment Charge		 - - - - - - - - 0.00 0.00 22
Total Other Income / (Expense), net		 -7.59 -4.90 -4.79 -1.95 -2.89 -3.06 -2.98 -14 -15 -13 -17
Interest & Investment Income		 0.61 1.23 1.64 2.04 1.58 1.54 3.66 -7.92 -14 -16 -13
Other Income / (Expense), net		 -1.83 0.15 -0.64 0.74 -0.14 1.53 -1.44 -5.71 -1.24 2.52 -3.61
Income Tax Expense		 -0.55 -36 7.53 11 8.10 -2.77 9.03 3.36 3.26 2.93 47
Basic Earnings per Share		 $0.83 $2.79 $1.61 $1.90 $2.17 ($0.29) $0.13 ($0.52) ($0.19) ($0.60) ($3.70)
Weighted Average Basic Shares Outstanding		 27.34M 27.76M 28.08M 28.40M 27.79M 27.02M 27.11M 27.26M 27.44M 27.60M 27.80M
Diluted Earnings per Share		 $0.81 $2.74 $1.57 $1.85 $2.13 ($0.29) $0.12 ($0.52) ($0.19) ($0.60) ($3.70)
Weighted Average Diluted Shares Outstanding		 27.96M 28.31M 28.77M 29.08M 28.27M 27.02M 27.42M 27.26M 27.44M 27.60M 27.80M
Weighted Average Basic & Diluted Shares Outstanding		 27.40M 27.80M 28.10M 28.30M 27.80M 27.01M 27.19M 27.35M 27.55M 27.70M 28.02M

Quarterly Income Statements for Stoneridge

This table shows Stoneridge's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -6.13 2.79 -7.07 -6.11 -7.20 -9.36 -9.37 -77 -28 -5.28 -23
Consolidated Net Income / (Loss)		 -6.13 2.79 -7.07 -6.11 -7.20 -9.36 -9.37 -77 -28 -5.28 -23
Net Income / (Loss) Continuing Operations		 -6.13 2.79 -7.07 -6.11 -8.00 -11 -8.89 -77 -15 -5.28 -23
Total Pre-Tax Income 		-5.62 1.85 -3.66 -6.17 -6.43 -9.60 -6.92 -31 -13 -2.72 -26
Total Operating Income		 0.33 3.41 0.32 -4.43 -4.31 -4.20 -1.44 -30 -8.98 -1.19 -24
Total Gross Profit		 48 54 44 43 35 36 32 33 35 37 12
Total Revenue		 239 237 214 218 149 158 139 205 161 181 156
Operating Revenue		 239 237 214 218 149 158 139 205 161 181 156
Total Cost of Revenue		 191 183 169 176 114 121 107 172 126 145 144
Operating Cost of Revenue		 191 183 169 176 114 121 107 172 126 145 144
Total Operating Expenses		 48 50 44 47 40 41 34 63 44 38 35
Selling, General & Admin Expense		 30 32 27 29 26 26 23 29 33 26 24
Research & Development Expense		 18 18 18 18 14 15 11 12 11 12 11
Total Other Income / (Expense), net		 -5.95 -1.56 -3.97 -1.74 -2.12 -5.41 -5.49 -1.49 -4.39 -1.53 -1.82
Interest & Investment Income		 -3.91 -3.85 -4.36 -7.25 -2.95 -3.18 -4.03 -3.26 -3.92 -2.18 -1.95
Other Income / (Expense), net		 -2.04 2.30 0.38 1.88 0.83 -2.22 -1.46 1.77 -0.47 0.65 0.14
Income Tax Expense		 0.51 -0.94 3.41 -0.06 1.58 1.54 1.97 46 1.41 2.56 -2.69
Net Income / (Loss) Discontinued Operations		 - - - - 0.81 1.78 -0.48 - -13 0.00 0.00
Basic Earnings per Share		 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00) ($0.19) ($0.81)
Weighted Average Basic Shares Outstanding		 27.53M 27.61M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M 28.24M 28.39M
Diluted Earnings per Share		 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00) ($0.19) ($0.81)
Weighted Average Diluted Shares Outstanding		 27.53M 27.85M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M 28.24M 28.39M
Weighted Average Basic & Diluted Shares Outstanding		 27.67M 27.68M 27.69M 27.70M 27.85M 28.01M 28.02M 28.02M 28.24M 28.52M 28.55M

Annual Cash Flow Statements for Stoneridge

This table details how cash moves in and out of Stoneridge's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 11 -3.97 16 19 -12 4.52 12 -31 -14 31 -5.58
Net Cash From Operating Activities		 55 65 79 81 25 29 -36 6.81 4.95 48 34
Net Cash From Continuing Operating Activities		 55 65 79 81 25 29 -36 6.81 4.95 48 34
Net Income / (Loss) Continuing Operations		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Consolidated Net Income / (Loss)		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Depreciation Expense		 19 20 21 23 25 27 28 27 27 26 24
Amortization Expense		 3.83 3.62 6.76 6.73 6.58 5.93 6.65 8.06 8.13 8.85 9.96
Non-Cash Adjustments To Reconcile Net Income		 6.90 3.97 2.98 2.55 -30 6.89 -32 7.07 3.21 5.89 27
Changes in Operating Assets and Liabilities, net		 4.54 -38 2.63 -5.14 -37 -3.48 -42 -21 -28 23 76
Net Cash From Investing Activities		 -30 -24 -109 -28 -6.30 -34 28 -29 -37 -24 -22
Net Cash From Continuing Investing Activities		 -30 -24 -109 -28 -6.30 -34 28 -29 -37 -24 -22
Purchase of Property, Plant & Equipment		 -29 -24 -32 -29 -39 -32 -27 -32 -38 -24 -22
Acquisitions		 -1.70 - -77 - - - - -0.95 -0.35 -0.55 -0.37
Sale of Property, Plant & Equipment		 0.06 0.65 0.08 0.11 0.38 0.13 0.27 0.16 1.87 0.39 0.40
Net Cash From Financing Activities		 -11 -43 41 -34 -28 6.51 23 -7.30 17 11 -25
Net Cash From Continuing Financing Activities		 -11 -43 41 -34 -28 6.51 23 -7.30 17 11 -25
Repayment of Debt		 -31 -59 -53 -58 -85 -99 -112 -61 -134 -155 -94
Issuance of Debt		 23 16 98 28 114 113 138 61 153 167 69
Other Financing Activities, net		 -2.92 -0.45 -2.48 -4.21 -7.51 -1.77 -2.67 -7.07 -1.72 -0.80 -0.34
Effect of Exchange Rate Changes		 -2.08 -2.05 4.56 - -1.64 3.25 -3.04 - - - 7.52
Cash Interest Paid		 6.09 5.79 5.75 5.00 4.40 5.62 6.06 7.29 13 15 14
Cash Income Taxes Paid		 2.49 3.39 7.09 13 12 -0.25 11 6.18 10 9.26 10

Quarterly Cash Flow Statements for Stoneridge

This table details how cash moves in and out of Stoneridge's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents		 7.60 -6.33 12 18 7.28 -29 4.22 12 17 0.98 -8.07
Net Cash From Operating Activities		 9.11 8.65 11 19 10 11 3.60 8.83 -11 12 4.23
Net Cash From Continuing Operating Activities		 9.11 8.65 11 19 10 11 3.60 8.83 -11 12 4.23
Net Income / (Loss) Continuing Operations		 -6.13 2.79 -7.07 -6.11 -8.00 -9.36 -9.37 -77 -25 -5.28 -23
Consolidated Net Income / (Loss)		 -6.13 2.79 -7.07 -6.11 -7.20 -9.36 -9.37 -77 -28 -5.28 -23
Depreciation Expense		 6.60 6.45 6.64 6.45 5.43 5.35 7.19 5.76 3.43 3.37 3.36
Amortization Expense		 2.16 2.28 2.37 2.04 2.05 2.49 2.58 2.83 2.78 2.66 2.57
Non-Cash Adjustments To Reconcile Net Income		 1.87 1.17 1.66 1.20 1.29 1.46 1.35 23 14 0.79 -0.11
Changes in Operating Assets and Liabilities, net		 4.61 -4.03 7.15 16 9.33 11 1.86 55 -6.79 11 21
Net Cash From Investing Activities		 -5.71 -7.24 -6.04 -5.47 -5.99 -3.23 -6.37 -6.24 58 -4.55 -4.48
Net Cash From Continuing Investing Activities		 -5.71 -7.24 -6.04 -5.47 -5.99 -3.23 -6.37 -6.24 58 -4.55 -4.48
Purchase of Property, Plant & Equipment		 -5.80 -7.13 -6.13 -5.25 -6.07 -3.28 -6.30 -6.20 -0.84 -4.57 -4.46
Acquisitions		 - - - -0.29 - - -0.18 -0.10 - - -0.07
Sale of Property, Plant & Equipment		 0.08 0.14 0.09 0.07 0.08 0.14 0.11 0.06 0.23 0.06 0.06
Net Cash From Financing Activities		 5.39 -7.07 5.81 6.99 -0.79 -41 6.72 9.34 -25 -6.36 -7.03
Net Cash From Continuing Financing Activities		 5.39 -7.07 5.81 6.99 -0.79 -41 6.72 9.34 -25 -6.36 -7.03
Repayment of Debt		 -32 -43 -42 -38 -7.26 -65 -13 -8.17 -48 -7.11 -7.07
Issuance of Debt		 38 36 23 45 6.70 25 4.70 33 22 2.00 0.06
Other Financing Activities, net		 -0.62 -0.05 -0.11 -0.02 -0.23 -0.08 -0.04 - -0.01 -1.24 -0.01
Effect of Exchange Rate Changes		 - - - -3.05 3.16 3.78 0.26 0.33 -0.61 -0.43 -0.79
Cash Interest Paid		 4.19 3.81 3.89 3.57 3.38 3.40 4.00 3.46 4.38 1.94 3.01

Annual Balance Sheets for Stoneridge

This table presents Stoneridge's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 364 395 559 560 602 621 665 652 680 622 551
Total Current Assets		 232 241 303 320 331 335 411 410 429 388 362
Cash & Equivalents		 54 50 66 81 69 74 86 55 41 72 53
Accounts Receivable		 95 113 142 139 139 137 150 158 167 138 89
Inventories, net		 61 60 73 79 93 91 138 153 188 151 106
Prepaid Expenses		 22 17 21 21 30 33 37 44 34 27 27
Other Current Nonoperating Assets		 - - - - - - - - - - 86
Plant, Property, & Equipment, net		 85 92 110 112 122 119 108 105 110 98 63
Total Noncurrent Assets		 47 62 145 127 148 167 147 138 140 136 127
Long-Term Investments		 10 22 32 28 32 54 42 44 47 54 22
Goodwill		 37 0.93 38 37 36 39 36 34 35 33 38
Intangible Assets		 - 39 75 62 58 55 50 46 47 40 38
Other Noncurrent Operating Assets		 - - - 0.00 22 19 18 14 11 10 9.57
Other Noncurrent Nonoperating Assets		 - - - - - - - - - - 20
Total Liabilities & Shareholders' Equity		 364 395 559 560 602 621 665 652 680 622 551
Total Liabilities		 258 202 315 276 312 325 369 371 392 376 371
Total Current Liabilities		 108 113 136 147 139 146 173 178 178 150 157
Short-Term Debt		 14 8.63 4.19 1.53 2.67 7.67 5.25 1.45 2.11 - 0.00
Accounts Payable		 55 63 79 88 81 86 98 110 112 83 62
Accrued Expenses		 - - - - - - - - - - 65
Other Current Nonoperating Liabilities		 - - - - - - - - - - 30
Total Noncurrent Liabilities		 150 90 179 129 174 179 196 193 214 226 214
Long-Term Debt		 4.46 8.06 3.85 0.98 0.45 - - 168 189 202 181
Noncurrent Deferred & Payable Income Tax Liabilities		 41 9.76 19 15 13 13 11 8.50 7.22 5.32 9.97
Other Noncurrent Operating Liabilities		 104 72 156 113 161 166 186 17 17 19 18
Other Noncurrent Nonoperating Liabilities		 - - - - - - - - - - 4.73
Total Equity & Noncontrolling Interests		 106 192 244 283 290 297 296 281 288 245 180
Total Preferred & Common Equity		 93 178 244 283 290 297 296 281 288 245 180
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 93 178 244 283 290 297 296 281 288 245 180
Common Stock		 199 207 228 232 226 234 232 233 227 226 219
Retained Earnings		 -32 45 92 146 207 212 216 202 197 180 77
Treasury Stock		 -4.21 -5.63 -7.12 -8.88 -51 -60 -55 -50 -43 -38 -27
Accumulated Other Comprehensive Income / (Loss)		 -70 -68 -70 -86 -91 -90 -97 -103 -93 -122 -89

Quarterly Balance Sheets for Stoneridge

This table presents Stoneridge's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets		 679 675 667 663 657 639 632 512 507 510
Total Current Assets		 436 431 422 414 418 393 384 348 344 350
Cash & Equivalents		 37 48 42 54 79 50 54 71 72 63
Accounts Receivable		 177 170 168 159 157 163 153 140 136 140
Inventories, net		 183 180 179 176 152 144 145 111 113 124
Prepaid Expenses		 39 33 33 25 30 36 32 26 24 23
Other Current Nonoperating Assets		 - - - - - - - 0.00 0.00 0.00
Plant, Property, & Equipment, net		 107 106 103 103 99 100 100 60 61 60
Total Noncurrent Assets		 136 138 142 145 140 146 147 104 101 100
Long-Term Investments		 45 49 55 54 55 54 56 22 23 25
Goodwill		 34 34 34 36 35 38 38 37 37 36
Intangible Assets		 45 45 44 44 41 43 41 36 33 31
Other Noncurrent Operating Assets		 11 9.55 8.72 11 9.61 11 13 9.02 8.49 7.53
Other Noncurrent Nonoperating Assets		 - - - - - - - 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 679 675 667 663 657 639 632 512 507 510
Total Liabilities		 405 398 396 391 404 379 381 356 358 386
Total Current Liabilities		 382 180 186 170 175 184 180 173 182 364
Short-Term Debt		 186 2.08 2.06 0.00 - - 0.95 - - 144
Accounts Payable		 131 109 108 98 97 106 102 103 108 118
Accrued Expenses		 - - - - - - - 69 74 102
Other Current Nonoperating Liabilities		 - - - - - - - 0.00 0.00 0.00
Total Noncurrent Liabilities		 24 218 210 221 229 195 201 183 176 22
Long-Term Debt		 0.00 194 187 196 203 164 170 156 151 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 7.41 6.85 6.28 6.34 5.34 5.37 4.94 8.73 8.69 4.30
Other Noncurrent Operating Liabilities		 16 17 16 19 21 25 26 18 16 18
Other Noncurrent Nonoperating Liabilities		 - - - - - - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 273 277 270 271 253 261 251 156 149 124
Total Preferred & Common Equity		 273 277 270 271 253 261 251 156 149 124
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 273 277 270 271 253 261 251 156 149 124
Common Stock		 226 224 225 225 221 218 218 216 205 205
Retained Earnings		 193 190 193 186 173 163 154 49 44 21
Treasury Stock		 -43 -39 -39 -39 -33 -28 -27 -20 -9.65 -9.35
Accumulated Other Comprehensive Income / (Loss)		 -103 -98 -108 -101 -108 -92 -93 -88 -90 -93

Annual Metrics And Ratios for Stoneridge

This table displays calculated financial ratios and metrics derived from Stoneridge's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 27,911,948.00 27,842,883.00 28,171,209.00 28,484,466.00 27,403,031.00 27,005,257.00 27,178,466.00 27,326,558.00 27,547,977.00 - 28,016,931.00
DEI Adjusted Shares Outstanding		 27,911,948.00 27,842,883.00 28,171,209.00 28,484,466.00 27,403,031.00 27,005,257.00 27,178,466.00 27,326,558.00 27,547,977.00 - 28,016,931.00
DEI Earnings Per Adjusted Shares Outstanding		 0.82 2.78 1.60 1.89 2.20 -0.29 0.13 -0.51 -0.19 - -3.67
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -2.39% 7.93% 18.46% 5.06% -3.68% -22.33% 18.90% 16.80% 8.43% -6.92% -5.18%
EBITDA Growth		 1,220.99% 39.07% 25.27% 14.44% 5.52% -73.59% 78.74% -33.94% 45.26% -20.11% -122.97%
EBIT Growth		 198.48% 70.20% 28.26% 19.41% 5.02% -108.63% 327.62% -119.88% 517.87% -81.53% -2,070.78%
NOPAT Growth		 258.04% 197.61% -42.19% 12.83% 13.30% -108.54% 178.68% -51.32% 337.34% -102.97% -10,032.81%
Net Income Growth		 133.94% 267.45% -40.39% 19.53% 11.97% -113.19% 142.84% -512.68% 63.13% -218.81% -522.34%
EPS Growth		 146.29% 238.27% -42.70% 17.83% 15.14% -113.62% 141.38% -533.33% 63.46% -215.79% -516.67%
Operating Cash Flow Growth		 176.58% 19.11% 20.88% 2.36% -69.66% 16.88% -226.56% 118.78% -27.33% 865.39% -28.75%
Free Cash Flow Firm Growth		 -58.82% -85.45% 259.59% 8.32% 42.48% -80.37% -25.01% -2,583.51% 82.10% 321.88% 15.26%
Invested Capital Growth		 -33.92% 127.19% 13.25% 14.11% 8.44% -7.73% -1.61% 102.21% 11.50% -17.86% -33.38%
Revenue Q/Q Growth		 -1.85% 2.65% 4.41% 0.39% -2.39% -0.10% 1.84% 3.15% -0.17% -1.23% -1.50%
EBITDA Q/Q Growth		 111.43% 7.45% 6.66% -0.62% -10.09% 24.71% -18.81% 36.71% 9.93% -21.24% -151.57%
EBIT Q/Q Growth		 2,160.82% 8.43% 7.97% -0.88% -14.84% 42.52% -44.15% 76.55% 44.96% -81.59% -147.76%
NOPAT Q/Q Growth		 1,334.05% 118.69% -40.94% -11.87% -9.66% 37.51% -73.80% 139.38% 0.30% -103.78% -185.15%
Net Income Q/Q Growth		 218.32% 135.90% -39.64% -11.29% -11.52% -8.59% -74.10% 31.26% 35.05% -123.72% -220.96%
EPS Q/Q Growth		 302.50% 119.20% -40.30% -11.48% -10.88% -3.57% -75.00% 29.73% 36.67% -122.22% -218.97%
Operating Cash Flow Q/Q Growth		 45.01% -12.60% -0.59% 7.08% -54.33% 121.37% -1,208,166.67% 116.72% -80.43% 22.02% -23.41%
Free Cash Flow Firm Q/Q Growth		 -60.27% -60.33% 69.83% -24.53% -20.85% -44.84% 153.39% -26,315.50% 82.34% 181.79% 116.14%
Invested Capital Q/Q Growth		 -27.90% 35.90% -6.54% -4.00% -0.74% 5.66% -11.58% 84.33% 3.78% -10.57% -31.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 27.45% 28.08% 30.10% 29.63% 25.62% 23.80% 21.66% 19.44% 20.63% 20.84% 19.87%
EBITDA Margin		 7.57% 9.75% 10.31% 11.23% 12.30% 4.18% 6.29% 3.56% 4.76% 4.09% -0.99%
Operating Margin		 4.31% 6.33% 6.96% 7.74% 8.54% -1.18% 2.00% 0.33% 1.32% -0.04% -4.48%
EBIT Margin		 4.03% 6.36% 6.88% 7.82% 8.53% -0.95% 1.81% -0.31% 1.19% 0.24% -4.90%
Profit (Net Income) Margin		 3.19% 10.86% 5.46% 6.22% 7.23% -1.23% 0.44% -1.56% -0.53% -1.82% -11.94%
Tax Burden Percent		 101.67% 192.86% 85.67% 82.77% 88.15% 74.13% 27.39% 131.41% 269.67% 121.53% 185.45%
Interest Burden Percent		 77.85% 88.60% 92.69% 96.04% 96.14% 174.77% 89.04% 385.30% -16.57% -634.78% 131.36%
Effective Tax Rate		 -2.70% -92.86% 14.33% 17.23% 11.85% 0.00% 72.61% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 37.86% 86.54% 33.79% 33.53% 34.20% -2.92% 2.41% 0.78% 2.42% -0.07% -10.09%
ROIC Less NNEP Spread (ROIC-NNEP)		 60.94% 105.06% 39.44% 35.17% 36.67% -0.56% 3.08% 62.34% -13.89% -18.16% -147.25%
Return on Net Nonoperating Assets (RNNOA)		 -19.18% -35.91% -13.13% -13.11% -13.16% 0.21% -1.26% -5.66% -4.24% -6.13% -38.30%
Return on Equity (ROE)		 18.68% 50.63% 20.66% 20.42% 21.04% -2.71% 1.15% -4.87% -1.82% -6.20% -48.39%
Cash Return on Invested Capital (CROIC)		 78.70% 8.80% 21.36% 20.35% 26.10% 5.12% 4.04% -66.86% -8.46% 19.54% 29.98%
Operating Return on Assets (OROA)		 6.81% 11.66% 11.90% 12.11% 12.25% -1.00% 2.17% -0.42% 1.74% 0.33% -7.20%
Return on Assets (ROA)		 5.39% 19.92% 9.45% 9.63% 10.38% -1.30% 0.53% -2.13% -0.78% -2.54% -17.54%
Return on Common Equity (ROCE)		 15.64% 46.04% 20.01% 20.42% 21.04% -2.71% 1.15% -4.87% -1.82% -6.20% -48.39%
Return on Equity Simple (ROE_SIMPLE)		 22.09% 42.38% 18.46% 19.01% 20.80% -2.68% 1.15% -5.00% 0.00% -6.74% 0.00%
Net Operating Profit after Tax (NOPAT)		 29 85 49 55 63 -5.36 4.22 2.05 8.99 -0.27 -27
NOPAT Margin		 4.43% 12.22% 5.96% 6.40% 7.53% -0.83% 0.55% 0.23% 0.92% -0.03% -3.14%
Net Nonoperating Expense Percent (NNEP)		 -23.09% -18.51% -5.65% -1.64% -2.48% -2.36% -0.67% -61.56% 16.32% 18.08% 137.16%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 0.46% 1.88% -0.06% -7.49%
Cost of Revenue to Revenue		 72.55% 71.92% 69.90% 70.37% 74.38% 76.20% 78.34% 80.56% 79.37% 79.16% 80.13%
SG&A Expenses to Revenue		 17.12% 15.97% 17.21% 16.00% 14.85% 17.36% 15.06% 11.86% 12.03% 12.93% 14.58%
R&D to Revenue		 6.02% 5.78% 5.93% 5.90% 6.26% 7.62% 8.59% 7.26% 7.28% 7.95% 7.26%
Operating Expenses to Revenue		 23.13% 21.75% 23.14% 21.89% 17.07% 24.98% 19.66% 19.11% 19.31% 20.88% 24.35%
Earnings before Interest and Taxes (EBIT)		 26 44 57 68 71 -6.14 14 -2.78 12 2.14 -42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 49 68 85 97 103 27 48 32 46 37 -8.53
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.44 2.76 2.64 2.48 2.77 2.75 1.81 2.10 1.87 0.71 0.90
Price to Tangible Book Value (P/TBV)		 7.32 3.57 4.94 3.81 4.10 4.04 2.56 2.93 2.63 1.01 1.55
Price to Revenue (P/Rev)		 0.64 0.71 0.78 0.81 0.96 1.26 0.70 0.65 0.55 0.19 0.19
Price to Earnings (P/E)		 18.14 6.36 14.25 13.04 13.33 0.00 157.52 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.51% 15.73% 7.02% 7.67% 7.50% 0.00% 0.63% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 6.33 3.30 3.59 3.38 3.69 3.95 2.39 1.88 1.64 0.78 1.25
Enterprise Value to Revenue (EV/Rev)		 0.59 0.65 0.67 0.69 0.84 1.07 0.54 0.73 0.66 0.28 0.31
Enterprise Value to EBITDA (EV/EBITDA)		 7.79 6.64 6.52 6.12 6.87 25.69 8.55 20.60 13.83 6.73 0.00
Enterprise Value to EBIT (EV/EBIT)		 14.62 10.19 9.77 8.79 9.91 0.00 29.65 0.00 55.41 116.61 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 13.30 5.30 11.28 10.73 11.22 0.00 98.11 320.86 71.53 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.93 6.90 7.03 7.37 28.76 24.31 0.00 96.86 129.95 5.23 7.88
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.40 52.16 17.84 17.68 14.70 73.94 58.65 0.00 0.00 3.59 3.34
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.17 0.09 0.03 0.01 0.01 0.03 0.02 0.60 0.67 0.82 1.01
Long-Term Debt to Equity		 0.04 0.04 0.02 0.00 0.00 0.00 0.00 0.60 0.66 0.82 1.01
Financial Leverage		 -0.31 -0.34 -0.33 -0.37 -0.36 -0.37 -0.41 -0.09 0.31 0.34 0.26
Leverage Ratio		 3.46 2.54 2.19 2.12 2.03 2.09 2.17 2.28 2.34 2.44 2.76
Compound Leverage Factor		 2.70 2.25 2.03 2.04 1.95 3.65 1.93 8.80 -0.39 -15.50 3.62
Debt to Total Capital		 14.71% 7.99% 3.19% 0.88% 1.07% 2.52% 1.74% 37.60% 39.96% 45.11% 50.16%
Short-Term Debt to Total Capital		 11.14% 4.13% 1.66% 0.54% 0.91% 2.52% 1.74% 0.32% 0.44% 0.00% 0.00%
Long-Term Debt to Total Capital		 3.57% 3.86% 1.53% 0.34% 0.15% 0.00% 0.00% 37.27% 39.51% 45.11% 50.16%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 10.67% 6.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 74.62% 85.42% 96.81% 99.12% 98.93% 97.48% 98.26% 62.40% 60.04% 54.89% 49.84%
Debt to EBITDA		 0.38 0.25 0.09 0.03 0.03 0.28 0.11 5.29 4.12 5.43 -21.22
Net Debt to EBITDA		 -0.95 -0.82 -1.05 -1.10 -0.96 -4.44 -2.53 2.19 2.23 2.05 -12.40
Long-Term Debt to EBITDA		 0.09 0.12 0.05 0.01 0.00 0.00 0.00 5.24 4.07 5.43 -21.22
Debt to NOPAT		 0.64 0.20 0.16 0.05 0.05 -1.43 1.24 82.38 21.31 -755.82 -6.70
Net Debt to NOPAT		 -1.62 -0.65 -1.82 -1.93 -1.57 22.41 -28.99 34.09 11.53 -285.65 -3.91
Long-Term Debt to NOPAT		 0.16 0.09 0.08 0.02 0.01 0.00 0.00 81.68 21.07 -755.82 -6.70
Altman Z-Score		 3.25 4.14 3.63 4.21 4.18 3.36 2.98 3.18 3.16 2.61 2.21
Noncontrolling Interest Sharing Ratio		 16.28% 9.07% 3.16% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.15 2.14 2.23 2.17 2.39 2.29 2.37 2.30 2.41 2.58 2.30
Quick Ratio		 1.38 1.45 1.53 1.49 1.50 1.44 1.36 1.20 1.16 1.40 0.90
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 59 8.64 31 34 48 9.42 7.06 -175 -31 70 80
Operating Cash Flow to CapEx		 191.15% 274.00% 245.87% 279.33% 62.70% 88.58% -135.44% 21.64% 13.50% 199.63% 158.60%
Free Cash Flow to Firm to Interest Expense		 9.33 1.38 5.37 7.13 11.09 1.54 1.36 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 8.61 10.40 13.64 17.11 5.67 4.68 -6.99 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 4.11 6.60 8.10 10.99 -3.37 -0.60 -12.14 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.69 1.83 1.73 1.55 1.44 1.06 1.20 1.37 1.47 1.40 1.47
Accounts Receivable Turnover		 6.45 6.69 6.45 6.15 6.01 4.71 5.37 5.83 6.01 5.97 7.60
Inventory Turnover		 7.07 8.26 8.63 7.98 7.19 5.37 5.28 4.99 4.55 4.24 5.35
Fixed Asset Turnover		 7.56 7.87 8.17 7.78 7.11 5.36 6.78 8.47 9.09 8.74 10.74
Accounts Payable Turnover		 8.22 8.50 8.12 7.29 7.36 5.92 6.57 6.98 6.97 7.36 9.46
Days Sales Outstanding (DSO)		 56.62 54.58 56.59 59.31 60.73 77.54 68.01 62.57 60.73 61.14 48.06
Days Inventory Outstanding (DIO)		 51.59 44.16 42.30 45.73 50.80 68.00 69.14 73.18 80.19 86.07 68.16
Days Payable Outstanding (DPO)		 44.40 42.96 44.96 50.08 49.58 61.65 55.57 52.33 52.34 49.60 38.58
Cash Conversion Cycle (CCC)		 63.81 55.79 53.94 54.96 61.95 83.89 81.58 83.42 88.58 97.61 77.64
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 60 136 155 176 191 176 174 351 391 321 214
Invested Capital Turnover		 8.54 7.08 5.67 5.24 4.54 3.53 4.40 3.43 2.63 2.55 3.22
Increase / (Decrease) in Invested Capital		 -31 76 18 22 15 -15 -2.84 177 40 -70 -107
Enterprise Value (EV)		 380 451 554 595 705 696 414 659 643 250 268
Market Capitalization		 413 493 644 702 803 816 537 589 539 174 162
Book Value per Share		 $3.34 $6.40 $8.66 $9.94 $10.58 $10.98 $10.89 $10.28 $10.44 $8.86 $6.42
Tangible Book Value per Share		 $2.02 $4.96 $4.63 $6.48 $7.15 $7.49 $7.72 $7.36 $7.45 $6.23 $3.73
Total Capital		 125 209 252 286 293 304 301 450 479 447 361
Total Debt		 18 17 8.04 2.52 3.13 7.67 5.25 169 191 202 181
Total Long-Term Debt		 4.46 8.06 3.85 0.98 0.45 0.00 0.00 168 189 202 181
Net Debt		 -46 -56 -90 -107 -99 -120 -122 70 104 76 106
Capital Expenditures (CapEx)		 29 24 32 29 39 32 27 31 37 24 21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 83 86 105 93 126 122 157 179 212 166 151
Debt-free Net Working Capital (DFNWC)		 138 137 171 174 195 196 243 233 253 238 204
Net Working Capital (NWC)		 124 128 167 173 193 189 238 232 251 238 204
Net Nonoperating Expense (NNE)		 8.00 9.44 4.10 1.61 2.55 2.59 0.81 16 14 16 76
Net Nonoperating Obligations (NNO)		 -46 -56 -90 -107 -99 -120 -122 70 104 76 34
Total Depreciation and Amortization (D&A)		 23 24 28 30 31 33 34 35 35 35 34
Debt-free, Cash-free Net Working Capital to Revenue		 12.93% 12.42% 12.79% 10.77% 15.10% 18.88% 20.44% 19.84% 21.77% 18.24% 17.56%
Debt-free Net Working Capital to Revenue		 21.37% 19.66% 20.79% 20.13% 23.41% 30.29% 31.54% 25.93% 25.95% 26.15% 23.72%
Net Working Capital to Revenue		 19.21% 18.42% 20.29% 19.96% 23.09% 29.11% 30.86% 25.76% 25.74% 26.15% 23.72%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.83 $2.79 $1.61 $1.90 $2.17 ($0.29) $0.13 ($0.52) ($0.19) ($0.60) ($3.70)
Adjusted Weighted Average Basic Shares Outstanding		 27.34M 27.76M 28.08M 28.40M 27.79M 27.02M 27.11M 27.26M 27.44M 27.60M 27.80M
Adjusted Diluted Earnings per Share		 $0.81 $2.74 $1.57 $1.85 $2.13 ($0.29) $0.12 ($0.52) ($0.19) ($0.60) ($3.70)
Adjusted Weighted Average Diluted Shares Outstanding		 27.96M 28.31M 28.77M 29.08M 28.27M 27.02M 27.42M 27.26M 27.44M 27.60M 27.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $2.17 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.79M 27.87M 28.18M 28.49M 27.41M 27.01M 27.19M 27.35M 27.55M 27.70M 28.02M
Normalized Net Operating Profit after Tax (NOPAT)		 19 31 49 55 33 -5.36 -11 2.05 8.99 -0.27 -12
Normalized NOPAT Margin		 3.02% 4.43% 5.96% 6.40% 3.98% -0.83% -1.39% 0.23% 0.92% -0.03% -1.38%
Pre Tax Income Margin		 3.14% 5.63% 6.38% 7.51% 8.20% -1.65% 1.61% -1.19% -0.20% -1.50% -6.44%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.08 7.05 9.81 14.35 16.45 -1.00 2.69 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 4.49 13.54 8.50 11.75 14.53 -0.88 0.81 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -0.42 3.25 4.26 8.23 7.41 -6.28 -2.47 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -0.02 9.75 2.95 5.62 5.49 -6.16 -4.34 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 4.10% 0.00% 82.93% -62.83% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Stoneridge

This table displays calculated financial ratios and metrics derived from Stoneridge's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding		 27,553,610.00 27,671,231.00 27,677,748.00 - 27,695,248.00 27,846,292.00 28,006,494.00 28,016,931.00 28,016,931.00 28,235,245.00 28,522,874.00
DEI Adjusted Shares Outstanding		 27,553,610.00 27,671,231.00 27,677,748.00 - 27,695,248.00 27,846,292.00 28,006,494.00 28,016,931.00 28,016,931.00 28,235,245.00 28,522,874.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.22 0.10 -0.26 - -0.26 -0.34 -0.33 -2.75 -1.00 -0.19 -0.80
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -0.90% -11.15% -10.22% -4.91% -37.67% -3.84% -1.67% -6.00% 7.91% 15.13% 12.38%
EBITDA Growth		 111.25% 36.28% -41.52% -62.80% -43.33% -87.46% -58.06% -422.66% -180.93% 286.09% -358.02%
EBIT Growth		 67.07% 193.36% -91.15% -136.83% -104.16% -205.75% -914.45% -985.36% -171.42% 91.60% -716.01%
NOPAT Growth		 108.22% 69.24% -93.07% -155.15% -1,400.91% -135.49% -1,140.95% -565.34% -108.50% 71.69% -1,557.56%
Net Income Growth		 17.06% 193.12% -425.66% -302.18% -17.47% -435.93% -32.55% -1,157.92% -287.95% 43.63% -144.51%
EPS Growth		 18.52% 190.91% -425.00% -300.00% -18.18% -440.00% -30.77% -1,154.55% -284.62% 44.12% -138.24%
Operating Cash Flow Growth		 199.21% 92.55% 1,197.45% 81.19% 10.76% 23.55% -66.49% -54.08% -213.98% 38.26% 3.58%
Free Cash Flow Firm Growth		 -1,286.61% 105.83% 109.75% 292.27% 128.34% 301.68% 147.84% 29.70% 88.72% 194.44% 156.14%
Invested Capital Growth		 92.09% -1.32% -4.68% -17.86% -14.37% -11.54% -12.97% -33.38% -31.85% -35.97% -42.67%
Revenue Q/Q Growth		 4.20% -0.88% -9.80% 2.07% -31.70% 4.62% -7.76% -2.43% -21.60% 12.77% -14.10%
EBITDA Q/Q Growth		 -55.71% 104.42% -32.71% -38.94% -32.53% -61.68% 125.03% -569.78% 83.08% 269.67% -422.55%
EBIT Q/Q Growth		 -124.57% 434.49% -87.74% -465.52% -36.24% -118.59% 5.60% -387.11% 65.93% 94.30% -4,287.38%
NOPAT Q/Q Growth		 -95.88% 2,114.40% -95.70% -1,507.62% 2.89% 19.35% -26.07% -799.70% 69.57% 86.77% -1,902.19%
Net Income Q/Q Growth		 -302.58% 145.48% -353.77% 13.52% -17.70% -30.06% -0.13% -720.71% 63.70% 81.10% -334.29%
EPS Q/Q Growth		 -300.00% 145.45% -360.00% 15.38% -18.18% -30.77% 0.00% -711.76% 63.77% 81.00% -326.32%
Operating Cash Flow Q/Q Growth		 -14.18% -5.01% 24.29% 78.81% -47.54% -1.89% -66.29% 145.01% -230.23% 207.10% -65.68%
Free Cash Flow Firm Q/Q Growth		 -419.10% 105.53% 79.43% 273.58% -23.50% -22.81% 10.71% 95.50% 11.31% 18.80% 1.96%
Invested Capital Q/Q Growth		 -3.74% -3.71% -0.91% -10.57% 0.36% -0.53% -2.52% -31.54% 2.67% -6.55% -12.72%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 20.22% 22.67% 20.81% 19.55% 23.65% 21.47% 20.34% 16.16% 21.73% 20.31% 7.38%
EBITDA Margin		 2.95% 6.09% 4.54% 2.72% 2.68% 0.79% 1.94% -9.33% -2.01% 3.03% -11.37%
Operating Margin		 0.14% 1.44% 0.15% -2.03% -2.89% -1.14% -1.56% -14.38% -5.58% -0.66% -15.27%
EBIT Margin		 -0.71% 2.41% 0.33% -1.17% -2.34% -2.65% -2.71% -13.52% -5.87% -0.30% -15.18%
Profit (Net Income) Margin		 -2.56% 1.18% -3.31% -2.80% -4.83% -4.11% -4.46% -37.49% -17.36% -2.91% -14.71%
Tax Burden Percent		 109.08% 150.59% 193.33% 99.03% 111.93% 102.68% 96.47% 248.17% 208.90% 193.90% 89.50%
Interest Burden Percent		 329.38% 32.44% -523.18% 241.64% 184.69% 151.14% 170.63% 111.76% 141.45% 504.82% 108.26%
Effective Tax Rate		 0.00% -50.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.33% 5.59% 0.26% -3.62% -4.73% -2.05% -2.84% -32.37% -12.58% -1.56% -39.70%
ROIC Less NNEP Spread (ROIC-NNEP)		 -65.40% 3.02% -7.34% -6.97% -9.68% -11.93% -12.29% -134.16% -45.06% -9.18% -50.43%
Return on Net Nonoperating Assets (RNNOA)		 -2.29% 1.00% -2.59% -2.35% -3.08% -3.43% -3.52% -34.89% -14.66% -2.62% -15.67%
Return on Equity (ROE)		 -1.96% 6.60% -2.33% -5.98% -7.82% -5.48% -6.36% -67.27% -27.24% -4.18% -55.37%
Cash Return on Invested Capital (CROIC)		 -105.42% 3.44% 6.71% 19.54% 14.47% 10.21% 11.05% 29.98% 26.71% 33.15% 36.43%
Operating Return on Assets (OROA)		 -1.03% 3.36% 0.45% -1.63% -2.87% -3.56% -3.66% -19.86% -8.77% -0.47% -24.29%
Return on Assets (ROA)		 -3.71% 1.64% -4.53% -3.91% -5.93% -5.52% -6.02% -55.07% -25.92% -4.55% -23.54%
Return on Common Equity (ROCE)		 -1.96% 6.60% -2.33% -5.98% -7.82% -5.48% -6.36% -67.27% -27.24% -4.18% -55.37%
Return on Equity Simple (ROE_SIMPLE)		 -1.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.23 5.13 0.22 -3.10 -3.01 -1.82 -2.30 -21 -6.28 -0.83 -17
NOPAT Margin		 0.10% 2.16% 0.10% -1.42% -2.02% -0.80% -1.09% -10.07% -3.91% -0.46% -10.69%
Net Nonoperating Expense Percent (NNEP)		 65.73% 2.57% 7.60% 3.35% 4.95% 9.88% 9.45% 101.78% 32.48% 7.62% 10.74%
Return On Investment Capital (ROIC_SIMPLE)		 0.05% 1.12% 0.05% -0.69% -0.66% -0.43% -0.54% -5.72% -2.01% -0.28% -6.21%
Cost of Revenue to Revenue		 79.78% 77.33% 79.19% 80.45% 76.35% 78.53% 79.66% 83.84% 78.27% 79.69% 92.62%
SG&A Expenses to Revenue		 12.72% 13.45% 12.41% 13.12% 17.35% 14.40% 15.03% 14.37% 20.22% 14.37% 15.32%
R&D to Revenue		 7.36% 7.79% 8.25% 8.46% 9.19% 8.21% 6.87% 5.63% 7.09% 6.59% 7.33%
Operating Expenses to Revenue		 20.08% 21.23% 20.66% 21.58% 26.54% 22.61% 21.90% 30.54% 27.31% 20.96% 22.65%
Earnings before Interest and Taxes (EBIT)		 -1.71 5.70 0.70 -2.56 -3.48 -6.03 -5.69 -28 -9.45 -0.54 -24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 7.06 14 9.71 5.93 4.00 1.81 4.07 -19 -3.24 5.49 -18
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.83 1.63 1.14 0.71 0.50 0.75 0.85 0.90 0.87 1.39 1.53
Price to Tangible Book Value (P/TBV)		 2.57 2.29 1.62 1.01 0.72 1.09 1.23 1.55 1.62 2.60 3.31
Price to Revenue (P/Rev)		 0.52 0.47 0.34 0.19 0.16 0.22 0.24 0.19 0.16 0.23 0.21
Price to Earnings (P/E)		 0.00 238.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.42% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.61 1.47 1.11 0.78 0.61 0.80 0.88 1.25 0.91 1.28 1.36
Enterprise Value to Revenue (EV/Rev)		 0.62 0.57 0.43 0.28 0.24 0.29 0.31 0.31 0.23 0.29 0.27
Enterprise Value to EBITDA (EV/EBITDA)		 12.10 9.88 8.44 6.73 5.77 11.56 16.63 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 40.31 28.35 34.19 116.61 537.23 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 69.18 56.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 26.15 19.49 10.17 5.23 4.04 4.97 6.19 7.88 16.00 16.60 15.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 42.53 16.10 3.59 3.89 7.35 7.41 3.34 2.75 3.02 2.73
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.71 0.70 0.72 0.82 0.80 0.63 0.68 1.01 1.00 1.01 1.16
Long-Term Debt to Equity		 0.70 0.69 0.72 0.82 0.80 0.63 0.68 1.01 1.00 1.01 0.00
Financial Leverage		 0.03 0.33 0.35 0.34 0.32 0.29 0.29 0.26 0.33 0.28 0.31
Leverage Ratio		 2.43 2.47 2.46 2.44 2.51 2.46 2.48 2.76 2.86 2.80 3.04
Compound Leverage Factor		 8.01 0.80 -12.88 5.90 4.64 3.72 4.23 3.08 4.04 14.12 3.29
Debt to Total Capital		 41.48% 41.20% 41.98% 45.11% 44.53% 38.69% 40.52% 50.16% 50.05% 50.33% 53.62%
Short-Term Debt to Total Capital		 0.44% 0.45% 0.00% 0.00% 0.00% 0.00% 0.22% 0.00% 0.00% 0.00% 53.62%
Long-Term Debt to Total Capital		 41.04% 40.75% 41.98% 45.11% 44.53% 38.69% 40.30% 50.16% 50.05% 50.33% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 58.52% 58.80% 58.02% 54.89% 55.47% 61.31% 59.48% 49.84% 49.95% 49.67% 46.38%
Debt to EBITDA		 3.91 3.51 4.16 5.43 5.96 7.41 10.35 -21.22 -9.92 -12.92 -3.96
Net Debt to EBITDA		 1.98 1.71 1.87 2.05 2.04 2.72 3.73 -12.40 -4.04 -4.82 -1.52
Long-Term Debt to EBITDA		 3.87 3.47 4.16 5.43 5.96 7.41 10.29 -21.22 -9.92 -12.92 0.00
Debt to NOPAT		 -1.62 24.55 27.84 -755.82 -57.84 -23.61 -18.06 -6.70 -5.16 -5.36 -3.28
Net Debt to NOPAT		 -0.82 11.96 12.49 -285.65 -19.79 -8.67 -6.50 -3.91 -2.10 -2.00 -1.26
Long-Term Debt to NOPAT		 -1.60 24.28 27.84 -755.82 -57.84 -23.61 -17.96 -6.70 -5.16 -5.36 0.00
Altman Z-Score		 3.04 2.94 2.70 2.59 2.23 2.40 2.42 2.30 2.42 2.62 1.96
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.39 2.27 2.44 2.58 2.39 2.14 2.13 2.30 2.02 1.89 0.96
Quick Ratio		 1.21 1.13 1.25 1.40 1.35 1.16 1.15 0.90 1.22 1.14 0.56
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -180 9.97 18 67 51 40 44 87 96 115 117
Operating Cash Flow to CapEx		 159.42% 123.90% 178.09% 371.18% 168.49% 340.59% 58.24% 143.90% -1,894.40% 273.06% 95.96%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.45 1.40 1.37 1.40 1.23 1.34 1.35 1.47 1.49 1.57 1.60
Accounts Receivable Turnover		 5.63 5.34 5.48 5.97 5.00 5.30 5.61 7.60 5.88 6.00 6.24
Inventory Turnover		 4.40 4.20 4.05 4.24 3.87 4.30 4.31 5.35 5.34 5.64 5.67
Fixed Asset Turnover		 9.11 9.02 8.75 8.74 7.96 8.64 8.58 10.74 10.95 11.13 11.40
Accounts Payable Turnover		 6.36 6.08 6.35 7.36 6.23 6.50 6.94 9.46 7.00 6.78 6.95
Days Sales Outstanding (DSO)		 64.85 68.35 66.63 61.14 72.93 68.87 65.04 48.06 62.05 60.81 58.52
Days Inventory Outstanding (DIO)		 82.97 86.87 90.22 86.07 94.28 84.80 84.69 68.16 68.37 64.76 64.35
Days Payable Outstanding (DPO)		 57.41 60.00 57.51 49.60 58.63 56.11 52.59 38.58 52.12 53.85 52.54
Cash Conversion Cycle (CCC)		 90.40 95.22 99.35 97.61 108.59 97.56 97.13 77.64 78.30 71.72 70.32
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 377 363 359 321 323 321 313 214 220 205 179
Invested Capital Turnover		 3.40 2.58 2.50 2.55 2.34 2.57 2.60 3.22 3.22 3.41 3.71
Increase / (Decrease) in Invested Capital		 181 -4.84 -18 -70 -54 -42 -47 -107 -103 -115 -133
Enterprise Value (EV)		 608 534 398 250 197 256 275 268 199 263 245
Market Capitalization		 508 442 310 174 127 196 213 162 135 207 190
Book Value per Share		 $10.06 $9.77 $9.80 $8.86 $9.14 $9.36 $8.97 $6.42 $5.57 $5.28 $4.36
Tangible Book Value per Share		 $7.17 $6.96 $6.92 $6.23 $6.40 $6.48 $6.17 $3.73 $2.99 $2.82 $2.01
Total Capital		 474 460 468 447 456 425 422 361 313 300 268
Total Debt		 196 189 196 202 203 164 171 181 156 151 144
Total Long-Term Debt		 194 187 196 202 203 164 170 181 156 151 0.00
Net Debt		 99 92 88 76 70 60 62 106 64 56 55
Capital Expenditures (CapEx)		 5.71 6.98 6.04 5.18 5.99 3.14 6.19 6.14 0.61 4.51 4.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 205 196 190 166 164 160 151 151 105 91 67
Debt-free Net Working Capital (DFNWC)		 253 238 245 238 243 209 205 204 175 162 130
Net Working Capital (NWC)		 251 236 245 238 243 209 204 204 175 162 -14
Net Nonoperating Expense (NNE)		 6.36 2.34 7.29 3.01 4.18 7.54 7.08 56 22 4.44 6.26
Net Nonoperating Obligations (NNO)		 99 92 88 76 70 60 62 34 64 56 55
Total Depreciation and Amortization (D&A)		 8.77 8.73 9.01 8.49 7.48 7.84 9.77 8.60 6.21 6.03 5.93
Debt-free, Cash-free Net Working Capital to Revenue		 21.03% 20.73% 20.70% 18.24% 20.01% 18.17% 17.30% 17.56% 12.01% 10.11% 7.29%
Debt-free Net Working Capital to Revenue		 26.00% 25.19% 26.59% 26.15% 29.68% 23.84% 23.47% 23.72% 20.09% 18.09% 14.23%
Net Working Capital to Revenue		 25.79% 24.97% 26.59% 26.15% 29.68% 23.84% 23.37% 23.72% 20.09% 18.09% -1.49%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00) ($0.19) ($0.81)
Adjusted Weighted Average Basic Shares Outstanding		 27.53M 27.61M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M 28.24M 28.39M
Adjusted Diluted Earnings per Share		 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00) ($0.19) ($0.81)
Adjusted Weighted Average Diluted Shares Outstanding		 27.53M 27.85M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M 28.24M 28.39M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.67M 27.68M 27.69M 27.70M 27.85M 28.01M 28.02M 28.02M 28.24M 28.52M 28.55M
Normalized Net Operating Profit after Tax (NOPAT)		 0.23 2.38 0.22 -3.10 -3.01 -1.82 -2.30 -21 -6.28 -0.83 -17
Normalized NOPAT Margin		 0.10% 1.01% 0.10% -1.42% -2.02% -0.80% -1.09% -10.07% -3.91% -0.46% -10.69%
Pre Tax Income Margin		 -2.35% 0.78% -1.71% -2.83% -4.31% -4.00% -4.62% -15.11% -8.31% -1.50% -16.43%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Stoneridge’s second-quarter 2026 results show improving operating momentum, but profitability remains unresolved. Revenue increased to $181.4 million from $160.8 million in Q1 2026 and $157.5 million in the restated Q2 2025 period. Gross profit rose to $36.8 million, although the gross margin of approximately 20.3% was below the 23.1% recorded a year earlier. Operating expenses fell sharply from $43.9 million in Q1 to $38.0 million in Q2, narrowing the operating loss to $1.2 million from $9.0 million in Q1.

The company’s cash flow also improved substantially. Operating cash flow turned positive at $12.3 million in Q2 2026, compared with an $11.5 million outflow in Q1 and $10.7 million of inflow in the year-ago quarter. After $4.6 million of capital expenditures, Stoneridge generated approximately $7.8 million of operating free cash flow. Cash increased to $71.5 million at quarter-end, while accounts receivable and inventories have declined meaningfully from 2024 levels, suggesting better working-capital management.

However, Stoneridge continues to report net losses and carries considerable financial obligations. The Q2 net loss was $5.3 million, or $0.19 per diluted share, following a $27.9 million loss in Q1 that included a $13.1 million loss from discontinued operations. Long-term debt stood at $151.1 million, and cash interest paid was $1.9 million during the quarter. Total equity fell to $149.1 million from $270.5 million in Q2 2024, reflecting accumulated losses and other comprehensive losses. Investors should also note that several 2025 and 2024 figures were restated, which complicates direct comparisons.

  • Revenue recovery: Q2 2026 revenue increased approximately 15% from the restated year-ago quarter and 13% sequentially.
  • Improving cost control: Operating expenses declined by $5.9 million from Q1 2026, helping reduce the operating loss by roughly $7.8 million.
  • Positive operating cash flow: Q2 operating cash flow reached $12.3 million, more than offsetting the company’s $4.6 million in capital expenditures.
  • Stronger liquidity: Cash and equivalents rose to $71.5 million, while the current ratio was approximately 1.9 based on Q2 assets and liabilities.
  • Working-capital improvement: Accounts receivable declined to $135.7 million and inventory to $113.0 million, both substantially below their Q2 2024 levels.
  • Debt reduction: Long-term debt declined to $151.1 million from $203.2 million in Q1 2024 and $170.2 million in Q3 2025.
  • Divestiture-related cash: A $59.0 million divestiture inflow in Q1 2026 helped support liquidity, but this is a nonrecurring source of cash and should not be treated as ongoing operating performance.
  • Margin pressure: Despite higher sales, Q2 gross margin declined year over year, indicating that revenue growth has not yet translated into consistent margin expansion.
  • Persistent net losses: Stoneridge has reported net losses in each of the listed 2024 and 2025 quarterly income statements and remained unprofitable in both quarters of 2026.
  • Reduced equity cushion: Total equity fell to $149.1 million from $270.5 million in Q2 2024, leaving shareholders with less balance-sheet protection against further losses.
11/10/26 04:51 PM ETAI Generated. May Contain Errors.

Stoneridge Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Stoneridge's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Stoneridge's net income appears to be on a downward trend, with a most recent value of -$102.84 million in 2025, compared with $20.57 million in 2015. The previous period was -$16.52 million in 2024. See Stoneridge's forecast for analyst expectations on what's next for the company.

Stoneridge's total operating income in 2025 was -$38.61 million, based on the following breakdown:
  • Total Gross Profit: $171.15 million
  • Total Operating Expenses: $209.76 million

Over the last 10 years, Stoneridge's total revenue changed from $644.81 million in 2015 to $861.26 million in 2025, a change of 33.6%.

In the past 12 quarters, Stoneridge's cash and equivalents has ranged from $36.76 million in Q3 2023 to $79.11 million in Q1 2025, and is currently $63.45 million as of their latest financial filing in Q3 2026.

Stoneridge had total debt of $180.94 million at the end of 2025, a 10.2% decrease from 2024, and a 885.4% increase since 2015.

Over the last 10 years, Stoneridge's book value per share changed from 3.34 in 2015 to 6.42 in 2025, a change of 92.3%.


Related Companies

Financial statements for NYSE:SRI last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Black Friday Bombshell (for traders)
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...
Behind the Markets | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...
Porter & Company | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
It’s now or never
Anthropic's Claude now generates more revenue than ChatGPT, and the company is about to go public at a $1.5 tr...
Paradigm Press | Sponsoredtc pixel
The One AI Stock to Watch in 2027
In 2019, Charles Mizrahi named Marvell Technology his top AI pick. It's since climbed 700 percent. Now he's...
Prosperity Research | Sponsoredtc pixel
Have You Heard of Tokenized Gold?
$1.6 billion has already moved into tokenized gold, and BlackRock CEO Larry Fink wants to tokenize $110 trilli...
Decentralized Masters | Sponsoredtc pixel